SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-16-012164
Filing Date
2016-03-02
Accepted
2016-03-02 16:15:21
Documents
3
Period of Report
2016-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k4q15earningsrelease.htm 8-K 20966
2 EXHIBIT 99.1 a4q15earningspressrelease.htm EX-99.1 97538
3 ljpcpressrelease_image1a02.jpg GRAPHIC 21134
  Complete submission text file 0001628280-16-012164.txt   148897
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 161477233
SIC: 2836 Biological Products, (No Diagnostic Substances)